Novavax to start human trials for Covid-19 vaccine candidate in Australia
Results of the first portion of trials are expected for July
Company
Novavax, Inc.
NASDAQ:NVAX
Novavax is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like particle (VLP) technology.
32 stories · page 2 of 2
Novavax shares surge following positive Phase 2 trial of flu vaccine
The clinical-stage biotech plans to meet with the FDA in the first half of the year to discuss the Phase 2 clinical trial results
Shares of Novavax slide after company's public offering was priced lower than previous stock close
The stock was priced 21% lower than previous closing price
Novavax shares leap pre-market after a study of its new flu vaccine approach showed stronger results than standard vaccine
Novavax said its NanoFlu recombinant vaccine was 47% to 64% more effective against different strains of H3N2 than the standard flu vaccine
Novavax soars on positive phase III trial of its RSV vaccine
Those who were given the RSV F vaccine had a 52% reduction in recent respiratory syncytial virus (RSV) infection
Archive
Oracle shares fall despite reiterated recommendation
Tech group Oracle Corp was reiterated as Neutral with a share price target of $41 by brokers at Wedbush on Friday but Novavax shares endure a drubbing
Novavax shares collapse after failed Phase III trial
The company’s respiratory syncytial virus vaccine did meet the primary or secondary objectives of the trial
US shares end down on oil, banks, but resilient on week
US stocks ended Friday lower after oil prices and a spat involving Deutsche Bank saw investors flee energy and banking stocks – but resilient on the week
Trending: American Apparel, Twitter, McDonald’s, Naked Brands, Oncomed Pharma & more
Clothing retailer American Apparel was given the green light to exit bankruptcy, and now a group of hedge funds are set to takeover the group.
Novavax to offer $200mln in convertible senior notes due 2023
The proceeds will be used to advance its clinical-stage vaccine candidates.